tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market
VYNE
VYNE Therapeutics
RESEARCH TOOLSreports

VYNE Therapeutics (VYNE) Income Statement

1,902 Followers

VYNE Therapeutics Income Statement

Last quarter (Q4 2025), VYNE Therapeutics's total revenue was $130.00K, an increase of 54.76% from the same quarter last year. In Q4, VYNE Therapeutics's net income was $-4.84M. See VYNE Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 570.00K$ 501.00K$ 424.00K$ 477.00K$ 931.00K
Gross Profit
$ 547.00K$ 501.00K$ 424.00K$ 477.00K$ 931.00K
Operating Expenses
$ 30.30M$ 44.14M$ 29.68M$ 34.77M$ 39.84M
Depreciation and Amortization
$ 0.00$ 4.00K$ 0.00$ 72.00K$ 109.00K
EBITDA
$ -26.73M$ -43.63M$ -29.26M$ -34.22M$ -38.80M
Operating Income
$ -29.75M$ -43.64M$ -29.26M$ -34.30M$ -38.91M
Other Income/Expenses
$ 3.02M$ 3.83M$ 1.39M$ 363.00K$ -4.85M
Pretax Income
$ -26.73M$ -39.80M$ -27.87M$ -33.93M$ -43.76M
Net Income
$ -26.48M$ -39.83M$ -28.45M$ -23.21M$ -73.33M
Per Share Metrics
Basic EPS
$ -0.62$ -0.93$ -2.77$ -10.65$ -25.65
Diluted EPS
$ -0.62$ -0.93$ -2.77$ -10.65$ -25.65
Weighted Average Shares Outstanding
 42.77M 42.59M 10.27M 3.19M 2.86M
Weighted Average Shares Outstanding (Diluted)
 42.77M 42.59M 10.27M 3.19M 2.86M
Currency in USD

VYNE Therapeutics Earnings and Revenue History